Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2007
Limitations of CT during PET/CT
Marc J Gollub, Richard Hong, Debra M Sarasohn, et al.
The Journal of Urology
|
July 4, 2006
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy
Maximiliano Sorbellini, Michael W Kattan, Mark E Snyder, et al.
Journal of Thrombosis and Thrombolysis
|
October 4, 2016
Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study
Simon Mantha, Eva Laube, Yimei Miao, et al.
Gynecologic Oncology
|
April 20, 2019
Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease
Amanika Kumar, Shannon Sheedy, Bohyun Kim, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 12, 2019
Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience
Gerald A Soff, Jodi Mones, Cy Wilkins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 9, 2010
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller
Dennis S Chi, Joyce N Barlin, Pedro T Ramirez, et al.
Radiology
|
June 22, 2013
Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy
Yulia Lakhman, Oguz Akin, Kay J Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia
Gerald A Soff, Yimei Miao, Gemma Bendheim, et al.
Gynecologic Oncology
|
June 11, 2020
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative
Alli M Straubhar, Olga T Filippova, Renee A Cowan, et al.
Gynecologic Oncology
|
January 22, 2020
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
Karen A Cadoo, Rachel N Grisham, Roisin E O'Cearbhaill, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 18, 2007
Limitations of CT during PET/CT
Marc J Gollub, Richard Hong, Debra M Sarasohn, et al.
The Journal of Urology
|
July 4, 2006
Prognostic nomogram for renal insufficiency after radical or partial nephrectomy
Maximiliano Sorbellini, Michael W Kattan, Mark E Snyder, et al.
Journal of Thrombosis and Thrombolysis
|
October 4, 2016
Safe and effective use of rivaroxaban for treatment of cancer-associated venous thromboembolic disease: a prospective cohort study
Simon Mantha, Eva Laube, Yimei Miao, et al.
Gynecologic Oncology
|
April 20, 2019
Models to predict outcomes after primary debulking surgery: Independent validation of models to predict suboptimal cytoreduction and gross residual disease
Amanika Kumar, Shannon Sheedy, Bohyun Kim, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 12, 2019
Rivaroxaban treatment of cancer-associated venous thromboembolism: Memorial Sloan Kettering Cancer Center institutional experience
Gerald A Soff, Jodi Mones, Cy Wilkins, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
April 9, 2010
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller
Dennis S Chi, Joyce N Barlin, Pedro T Ramirez, et al.
Radiology
|
June 22, 2013
Stage IB1 cervical cancer: role of preoperative MR imaging in selection of patients for fertility-sparing radical trachelectomy
Yulia Lakhman, Oguz Akin, Kay J Park, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced Thrombocytopenia
Gerald A Soff, Yimei Miao, Gemma Bendheim, et al.
Gynecologic Oncology
|
June 11, 2020
A multimodality triage algorithm to improve cytoreductive outcomes in patients undergoing primary debulking surgery for advanced ovarian cancer: A Memorial Sloan Kettering Cancer Center team ovary initiative
Alli M Straubhar, Olga T Filippova, Renee A Cowan, et al.
Gynecologic Oncology
|
January 22, 2020
A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
Karen A Cadoo, Rachel N Grisham, Roisin E O'Cearbhaill, et al.
Page
of 2